Financial

HCA Healthcare Reports First Quarter 2024 Results

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31,…

3 months ago

AI in Healthcare: Unveiling the Future with a 42.20% CAGR Through 2029

USA News Group Commentary VANCOUVER, BC, April 25, 2024 /PRNewswire/ -- Across several sectors the use of artificial intelligence (AI)…

3 months ago

Moderna and OpenAI Collaborate To Advance mRNA Medicine

Generative AI will help advance Moderna's broad and diverse portfolio to maximize the Company's impact on patientsModerna embeds OpenAI's generative…

3 months ago

19-Provider FQHC Coastal Bend Wellness Foundation Selects eClinicalWorks AI Solutions and Sunoh.ai to Reduce Physician Burnout

The advanced AI solutions and AI medical scribe technology to assist the community health center in streamlining workflows, reducing costs,…

3 months ago

Joint Study with Leading US Hospital to Assess Impact of FeelBetter’s Precision Population Health Platform on Polypharmacy Patient Management

Prospective Research to Evaluate Potential of FeelBetter’s AI-Powered Platform as a Tool to Aid in Improving Patient Outcomes, Reducing Healthcare…

3 months ago

Munich Re Life US and Clareto Usher in Next-Level Efficiency in Life Insurance Underwriting with Automated EHR Summarizer

Industry-leading digital solution ensures efficient and accurate use of Electronic Health Record data for life insurance underwritingNEW YORK--(BUSINESS WIRE)--#lifeinsurance--Munich Re…

3 months ago

GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset

The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in…

3 months ago

Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach

– Collaboration grants Palisade Bio access to cutting-edge expertise and tools in bioinformatics – Partnership marks a significant value-driving milestone…

3 months ago

Cerevance Publishes CVN293 in ACS Medicinal Chemistry Letters

Selective CVN293 may have treatment potential in multiple neurodegenerative conditionsBOSTON, April 22, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused…

3 months ago

BioXcel Therapeutics Announces Plan for Evaluating BXCL501 in the At-Home Setting to Expand Its Market Potential

Company plans to initiate SERENITY At-Home pivotal Phase 3 safety trial with 120 mcg dose following recent meeting with FDA…

3 months ago